IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,072 | +10.6% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $8,206 | -97.7% | 200 | -97.5% | 0.00% | -96.3% |
| Q3 2022 | $358,000 | +713.6% | 8,106 | +575.5% | 0.03% | +575.0% |
| Q2 2022 | $44,000 | -71.4% | 1,200 | -76.4% | 0.00% | -66.7% |
| Q4 2021 | $154,000 | +327.8% | 5,076 | +683.3% | 0.01% | +200.0% |
| Q4 2020 | $36,000 | +157.1% | 648 | +116.0% | 0.00% | +100.0% |
| Q3 2020 | $14,000 | -81.1% | 300 | -76.4% | 0.00% | -80.0% |
| Q2 2020 | $74,000 | +393.3% | 1,270 | +299.4% | 0.01% | 0.0% |
| Q1 2020 | $15,000 | -68.1% | 318 | -60.1% | 0.01% | +100.0% |
| Q3 2019 | $47,000 | -42.7% | 797 | -38.3% | 0.01% | -37.5% |
| Q2 2019 | $82,000 | -60.2% | 1,291 | -68.6% | 0.01% | -57.9% |
| Q4 2017 | $206,000 | -15.2% | 4,115 | -14.2% | 0.02% | -17.4% |
| Q3 2017 | $243,000 | +133.7% | 4,795 | +118.8% | 0.02% | +91.7% |
| Q4 2016 | $104,000 | -72.8% | 2,191 | -64.7% | 0.01% | -81.8% |
| Q4 2015 | $383,000 | – | 6,200 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |